The First Cohort homepage — asymmetric feature split layout with a dominant cancer research lead story beside secondary stories and a tertiary row below
The First Cohort
Medical research, with the receipts
Cancer
A Korean lab found cancer’s DNA-repair off-switch. In a mouse.
A tool compound strips the DNA-repair proteins tumors use to dodge PARP inhibitors. Preclinical only — but the gap between treated and control animals is the story.
Lena Marshall · 6 min read
Source: Preclinical study data, treated vs. control cohort at week 8
Metabolic
Where your sodium actually comes from
About 71% of dietary sodium arrives via processed food. The saltshaker accounts for 6–20%.
Sarah Okonkwo · 5 min
Drugs & FDA
Europe had this sunscreen in 1999. The FDA approved it Tuesday.
Sarah Okonkwo · 4 min
Infectious Disease
A DoD-funded fentanyl vaccine is headed to Phase 1
Marcus Chen · 7 min
Brain & Aging
The Alzheimer’s drug that bets the plaques are a symptom
Sarah Okonkwo · 5 min
Autoimmune
Fish oil rewired the T-cells in non-obese diabetic rats
Sarah Okonkwo · 4 min
Cancer
ALTAIR missed its endpoint. The press tour found something else.
Lena Marshall · 7 min
Nutrition
The thin trial behind England’s next supermarket-layout mandate
Marcus Chen · 6 min
Investigations
A Senate subcommittee just put the COVID-shot cancer question on the record
Marcus Chen · 8 min
Investigations
The $401 CBC and the $32 CBC are the same test
Lena Marshall · 5 min
Investigations
A 16-foot fire tornado burned an oil slick with 40% less soot